Sung et al., 2007 - Google Patents
Radical prostatectomy specimen processing: a critical appraisal of sampling methodsSung et al., 2007
View PDF- Document ID
- 2436923910279235999
- Author
- Sung M
- Davidson D
- Montironi R
- Lopez-Beltran A
- Cheng L
- Publication year
- Publication venue
- Current Diagnostic Pathology
External Links
Snippet
Radical prostatectomy gives the most accurate and detailed information available for determining prognosis and deciding about adjuvant therapy for prostate cancer. The consistency and reproducibility of observations from these specimens requires a …
- 238000005070 sampling 0 title abstract description 38
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/36—Embedding or analogous mounting of samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
- A61B10/0266—Pointed or sharp biopsy instruments means for severing sample
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lopez-Beltran et al. | Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis | |
Montironi et al. | Handling and pathology reporting of radical prostatectomy specimens | |
Moon et al. | Sublobar resection margin width does not affect recurrence of clinical N0 non‐small cell lung cancer presenting as GGO‐predominant nodule of 3 cm or less | |
Stromberg et al. | Trimming tumors for diagnosis and prognosis | |
Ehdaivand et al. | Incidental gynecologic neoplasms in morcellated uterine specimens: a case series with follow-up | |
Saegusa-Beecroft et al. | Three-dimensional quantitative ultrasound for detecting lymph node metastases | |
Xu et al. | The accuracy of frozen section diagnosis of pulmonary nodules: evaluation of inflation method during intraoperative pathology consultation with cryosection | |
Jhavar et al. | Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique | |
Megwalu et al. | Evaluation of a novel precision template‐guided biopsy system for detecting prostate cancer | |
Miller et al. | Absence of a relationship of size of primary colon carcinoma with metastasis and survival | |
Sakr et al. | Prostate: practice parameters, pathologic staging, and handling radical prostatectomy specimens | |
Zhang et al. | A new method of surgical margin assuring for abdominal radical trachelectomy in frozen section | |
Reggiani Bonetti et al. | Optimal processing of ESD specimens to avoid pathological artifacts | |
Baatrup et al. | Rectal adenocarcinoma and transanal endoscopic microsurgery. Diagnostic challenges, indications and short term results in 142 consecutive patients | |
Sung et al. | Radical prostatectomy specimen processing: a critical appraisal of sampling methods | |
Sung et al. | Contemporary approaches for processing and handling of radical prostactomy specimens | |
Jørgensen et al. | Pathology and resection margins following mastectomy prior to immediate breast reconstruction | |
Verbeke | Operative specimen handling and evaluation of resection margins | |
Ferreira et al. | Core needle biopsy in the diagnosis of head and neck lesions: a retrospective study of 3 years | |
Mondal et al. | Comparative study between intraoperative fine needle aspiration cytology/imprint cytology and frozen section in determination of tumour margin | |
Wu et al. | A novel localization device for small pulmonary nodules in thoracoscopic wedge resection with adequate margin distance: a retrospective study | |
Pekar et al. | Biobanking multifocal breast carcinomas: sample adequacy with regard to histology and DNA content | |
Rocco et al. | Histological Evaluations of RADICAL Prostatectomy Specimens | |
Provenzano et al. | Guidelines for the handling of benign and malignant surgical breast specimens | |
Wen et al. | Breast cancer pathology |